BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6593092)

  • 1. The pharmacokinetics of imipenem (thienamycin-formamidine) and the renal dehydropeptidase inhibitor cilastatin sodium in normal subjects and patients with renal failure.
    Verpooten GA; Verbist L; Buntinx AP; Entwistle LA; Jones KH; De Broe ME
    Br J Clin Pharmacol; 1984 Aug; 18(2):183-93. PubMed ID: 6593092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tolerance after repeated doses of imipenem/cilastatin in patients with severe renal failure.
    Verbist L; Verpooten GA; Giuliano RA; Debroe ME; Buntinx AP; Entwistle LA; Jones KH
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():115-20. PubMed ID: 3469184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An overview of the pharmacology of imipenem/cilastatin.
    Drusano GL
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():79-92. PubMed ID: 3546249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary recovery of N-formimidoyl thienamycin (MK0787) as affected by coadministration of N-formimidoyl thienamycin dehydropeptidase inhibitors.
    Norrby SR; Alestig K; Björnegård B; Burman LA; Ferber F; Huber JL; Jones KH; Kahan FM; Kahan JS; Kropp H; Meisinger MA; Sundelof JG
    Antimicrob Agents Chemother; 1983 Feb; 23(2):300-7. PubMed ID: 6573157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of imipenem and cilastatin in volunteers.
    Rogers JD; Meisinger MA; Ferber F; Calandra GB; Demetriades JL; Bland JA
    Rev Infect Dis; 1985; 7 Suppl 3():S435-46. PubMed ID: 3863219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic studies of imipenem/cilastatin in elderly patients.
    Finch RG; Craddock C; Kelly J; Deaney NB
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():103-7. PubMed ID: 3469182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of imipenem-cilastatin in neonates.
    Freij BJ; McCracken GH; Olsen KD; Threlkeld N
    Antimicrob Agents Chemother; 1985 Apr; 27(4):431-5. PubMed ID: 3859242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose pharmacokinetics of imipenem-cilastatin in neonates.
    Gruber WC; Rench MA; Garcia-Prats JA; Edwards MS; Baker CJ
    Antimicrob Agents Chemother; 1985 Apr; 27(4):511-4. PubMed ID: 3859243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical pharmacokinetics of an imipenem-cilastatin combination].
    Singlas E
    Presse Med; 1990 Apr; 19(13):598-605. PubMed ID: 2139939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thienamycin: development of imipenen-cilastatin.
    Kahan FM; Kropp H; Sundelof JG; Birnbaum J
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal clearance of imipenem in children.
    Jacobs RF; Kearns GL; Brown AL; Trang JM; Kluza RB
    Eur J Clin Microbiol; 1984 Oct; 3(5):471-4. PubMed ID: 6594236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple-dose pharmacokinetics of imipenem-cilastatin.
    Drusano GL; Standiford HC; Bustamante C; Forrest A; Rivera G; Leslie J; Tatem B; Delaportas D; MacGregor RR; Schimpff SC
    Antimicrob Agents Chemother; 1984 Nov; 26(5):715-21. PubMed ID: 6595963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem/cilastatin: pharmacokinetic profile in renal insufficiency.
    Gibson TP; Demetriades JL; Bland JA
    Am J Med; 1985 Jun; 78(6A):54-61. PubMed ID: 3859216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of imipenem and cilastatin after their simultaneous administration to the elderly.
    Toon S; Hopkins KJ; Garstang FM; Aarons L; Rowland M
    Br J Clin Pharmacol; 1987 Feb; 23(2):143-9. PubMed ID: 3470047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of radiolabeled imipenem and cilastatin in normal human volunteers.
    Norrby SR; Rogers JD; Ferber F; Jones KH; Zacchei AG; Weidner LL; Demetriades JL; Gravallese DA; Hsieh JY
    Antimicrob Agents Chemother; 1984 Nov; 26(5):707-14. PubMed ID: 6595962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple-dose study of imipenem/cilastatin in patients with end-stage renal disease undergoing long-term hemodialysis.
    Berman SJ; Sugihara JG; Nakamura JM; Kawahara KK; Wong EG; Musgrave JE; Wong LM; Siemsen AM
    Am J Med; 1985 Jun; 78(6A):113-6. PubMed ID: 3859209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
    Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL
    Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.
    Birnbaum J; Kahan FM; Kropp H; MacDonald JS
    Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of imipenem in healthy volunteers.
    Norrby SR; Björnegård B; Ferber F; Jones KH
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():109-24. PubMed ID: 6583194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
    Drusano GL; Standiford HC
    Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.